Artificial intelligence (AI) has great potential to transform healthcare, making it more efficient, equitable, and safe. To be able to use an AI-based tool in clinical settings it has to go through the regulatory approval process (CE marking). This process is not easy to navigate and can take a significant amount of time and resources.
Regulatory approval does not guarantee the adoption of a tool in clinics - hundreds of AI-based tools have received regulatory approval, nevertheless, only a few get adopted into clinical practice because of numerous barriers and challenges.
In this talk, researchers from the DNV Healthcare research program will talk about the main steps of the regulatory approval process, adoption challenges and ways to overcome those.
DNV is an independent assurance and risk management provider, operating in more than 100 countries globally. The Healthcare Research Programme is part of the Group Research and Development at DNV and works with partners through large-scale public-private research and innovation projects to address the data-sharing and infrastructure needs, legal and regulatory challenges, and gaps in trust that prevent the clinical implementation of precision medicine, AI, and new digital technologies.
More information on DNV Healthcare here.
Agenda
14:15 Welcome (Dennis Gan, SPARK Social Innovation)
14:20 DNV Healthcare talk - What to consider when adopting AI-based tools into clinical practice?
15:00 Discussion
15:30 Food and mingling
Registration deadline for food/drinks on 9th February
| Helga M. Br?gger |  |
|---|---|
| Helga M. Br?gger, is a principal researcher DNV GRD, Healthcare programme, with a background in radiology, information security, and project management. She holds an MD and a BA in Culture Studies and Oriental Languages from the University of Oslo. Br?gger is an advocate for responsible AI and has spoken extensively on the ethical implications of AI and the need for transparency and accountability in the development and deployment of AI systems. She is also a board member for several organizations, including the Norwegian Society of Radiology, NORDE (Norwegian Council for Digital Ethics), MIRA (Gemini Center for Medical Imaging Research and AI), Presimal (Presisjonsavbildning og ML for ? bedre pasientbehandlingen), MMIV (The Mohn Medical Imaging and Visualization Centre). |
| Oleg Agafonov |  |
|---|---|
| Oleg is a senior researcher at DNV R&D, Healthcare programme with background in computational biology and genomics. In DNV R&D Healthcare he develops new assurance methods and tools to enable the trustworthy adoption of novel digital technologies and precision medicine approaches in clinical settings. |
?About the SPARK Social Innovation Educational Forum
The SPARK forum is an open monthly meeting for project teams, partners, and everyone interested in how universities and academics engage with social innovation.